ProQR Therapeutics NV operates in the Commercial physical research sector.
In addition to historical fundamental analyses, the complete report available to purchase compares ProQR Therapeutics NV with three other
companies in this sector in UNITED STATES :
Kalvista Pharmaceuticals Inc
(2020
sales of $12.69 million
of which 100%
was Pharmaceuticals),
Cidara Therapeutics Inc
($12.07 million
of which 100%
was Care therapies), and
Reata Pharmaceuticals Inc
($9.02 million
).
Sales Analysis.
Sales increased substantially in 2020:
ProQR Therapeutics NV reported sales of $10.84 million
for the
year ending
December of 2020.
This
represents
an
increase of 401.9%
versus 2019, when the company's sales were $2.16 million.